Equities

Surgical Science Sweden AB

Surgical Science Sweden AB

Actions
  • Price (EUR)10.32
  • Today's Change0.44 / 4.45%
  • Shares traded400.00
  • 1 Year change-25.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments634434317
Total Receivables, Net192244180
Total Inventory154135113
Prepaid expenses11147.33
Other current assets, total------
Total current assets991826617
Property, plant & equipment, net775138
Goodwill, net3,3293,4443,019
Intangibles, net287301274
Long term investments4.774.374.97
Note receivable - long term------
Other long term assets------
Total assets4,7034,6503,978
LIABILITIES
Accounts payable416634
Accrued expenses4744104
Notes payable/short-term debt000
Current portion long-term debt/capital leases131513
Other current liabilities, total13318181
Total current liabilities235306232
Total long term debt401512
Total debt533025
Deferred income tax455249
Minority interest------
Other liabilities, total3741100
Total liabilities357413393
SHAREHOLDERS EQUITY
Common stock2.552.542.54
Additional paid-in capital3,3983,3793,379
Retained earnings (accumulated deficit)945855204
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity4,3454,2363,585
Total liabilities & shareholders' equity4,7034,6503,978
Total common shares outstanding515151
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.